Literature DB >> 17185790

Lifestyle choices, diet, and insulin sensitizers in polycystic ovary syndrome.

R J Norman1, G Homan, L Moran, M Noakes.   

Abstract

Polycystic ovary syndrome (PCOS) is significantly affected by environmental regulators impacting on genetic predisposition. Lifestyle changes can significantly modulate the phenotype of this disease. Diet, exercise, smoking, stress, and other factors adversely affect reproductive outcomes in PCOS. These influences can be modulated by structure change in an individual or group. Lifestyle choices should be discussed in this group of patients. The role of insulin sensitizers, including metformin, has still to be determined in this condition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17185790     DOI: 10.1385/ENDO:30:1:35

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  116 in total

Review 1.  Micronutrients and fetal growth.

Authors:  Caroline H D Fall; Chittaranjan S Yajnik; Shobha Rao; Anna A Davies; Nick Brown; Hannah J W Farrant
Journal:  J Nutr       Date:  2003-05       Impact factor: 4.798

2.  Aneuploidy 16 in human embryos increases significantly with maternal age.

Authors:  C A Benadiva; I Kligman; S Munné
Journal:  Fertil Steril       Date:  1996-08       Impact factor: 7.329

Review 3.  Obesity and reproductive disorders: a review.

Authors:  R J Norman; A M Clark
Journal:  Reprod Fertil Dev       Date:  1998       Impact factor: 2.311

4.  Women's experience of IVF: a follow-up study.

Authors:  K Hammarberg; J Astbury; H Baker
Journal:  Hum Reprod       Date:  2001-02       Impact factor: 6.918

5.  Recreational drug use and the risk of primary infertility.

Authors:  B A Mueller; J R Daling; N S Weiss; D E Moore
Journal:  Epidemiology       Date:  1990-05       Impact factor: 4.822

6.  Are women with polycystic ovary syndrome at an increased risk of pregnancy-induced hypertension and/or preeclampsia?

Authors:  M Fridström; H Nisell; P Sjöblom; T Hillensjö
Journal:  Hypertens Pregnancy       Date:  1999       Impact factor: 2.108

7.  Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.

Authors:  Jean-Patrice Baillargeon; Daniela J Jakubowicz; Maria J Iuorno; Salomon Jakubowicz; John E Nestler
Journal:  Fertil Steril       Date:  2004-10       Impact factor: 7.329

8.  Moderate to heavy caffeine consumption during pregnancy and relationship to spontaneous abortion and abnormal fetal growth: a meta-analysis.

Authors:  O Fernandes; M Sabharwal; T Smiley; A Pastuszak; G Koren; T Einarson
Journal:  Reprod Toxicol       Date:  1998 Jul-Aug       Impact factor: 3.143

9.  Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome.

Authors:  L J Moran; M Noakes; P M Clifton; L Tomlinson; C Galletly; R J Norman
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

Review 10.  Improving reproductive performance in overweight/obese women with effective weight management.

Authors:  Robert J Norman; Manny Noakes; Ruijin Wu; Michael J Davies; Lisa Moran; Jim X Wang
Journal:  Hum Reprod Update       Date:  2004 May-Jun       Impact factor: 15.610

View more
  6 in total

Review 1.  Understanding polycystic ovarian syndrome pathogenesis: an updated of its genetic aspects.

Authors:  A E Calogero; V Calabrò; M Catanuso; R A Condorelli; S La Vignera
Journal:  J Endocrinol Invest       Date:  2011-05-23       Impact factor: 4.256

Review 2.  Personalized Nutrition in the Management of Female Infertility: New Insights on Chronic Low-Grade Inflammation.

Authors:  Gemma Fabozzi; Giulia Verdone; Mariachiara Allori; Danilo Cimadomo; Carla Tatone; Liborio Stuppia; Marica Franzago; Nicolò Ubaldi; Alberto Vaiarelli; Filippo Maria Ubaldi; Laura Rienzi; Gianluca Gennarelli
Journal:  Nutrients       Date:  2022-05-03       Impact factor: 6.706

3.  Patterns of use of insulin-sensitizing agents among diabetic, borderline diabetic and non-diabetic women in the National Health and Nutrition Examination Surveys.

Authors:  Hind Beydoun; Vijaya Kancherla; Laurel Stadtmauer; May Beydoun
Journal:  Gynecol Endocrinol       Date:  2013-01-17       Impact factor: 2.260

4.  Impact of obesity on the risk for polycystic ovary syndrome.

Authors:  Bulent O Yildiz; Eric S Knochenhauer; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2007-10-09       Impact factor: 5.958

5.  Oriental medicine Kyung-Ok-Ko prevents and alleviates dehydroepiandrosterone-induced polycystic ovarian syndrome in rats.

Authors:  Minhee Jang; Min Jung Lee; Jin Moo Lee; Chun-Sik Bae; Sung-Hoon Kim; Jong Hoon Ryu; Ik-Hyun Cho
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

6.  Korean Red Ginseng alleviates dehydroepiandrosterone-induced polycystic ovarian syndrome in rats via its antiinflammatory and antioxidant activities.

Authors:  Jong Hee Choi; Minhee Jang; Eun-Jeong Kim; Min Jung Lee; Kyoung Sun Park; Seung-Hyun Kim; Jun-Gyo In; Yi-Seong Kwak; Dae-Hun Park; Seung-Sik Cho; Seung-Yeol Nah; Ik-Hyun Cho; Chun-Sik Bae
Journal:  J Ginseng Res       Date:  2019-08-26       Impact factor: 6.060

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.